Liver transplantation for colorectal liver metastases: Revisiting the concept

Transplant International

Volumn 23, Issue 7, 2010, Pages 679-685

  Foss, Aksel ^a   Adam, Rene ^b,c   Dueland, Svein ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b HÔPITAL PAUL BROUSSE   (France)

^c European Liver Transplant Registry (ELTR)   (France)

Author keywords

Colorectal cancer; Liver transplantation

Indexed keywords

AZATHIOPRINE; BEVACIZUMAB; CETUXIMAB; CYCLOPHOSPHAMIDE; FLUOROURACIL; GADOLINIUM; INTERFERON; IRINOTECAN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; OXALIPLATIN; PANITUMUMAB; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; RAPAMYCIN; TEMSIROLIMUS; ANTINEOPLASTIC AGENT;

ADVANCED CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CANCER; CONFERENCE PAPER; DIAGNOSTIC IMAGING; GRAFT VERSUS HOST REACTION; HEALTH CARE COST; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CANCER; KIDNEY CARCINOMA; LIVER METASTASIS; LIVER TRANSPLANTATION; METASTASIS; NEOPLASM; PATIENT SELECTION; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE; CLINICAL TRIAL; COLORECTAL TUMOR; LIVER NEOPLASMS; MORTALITY; PATHOLOGY; PILOT STUDY; SECONDARY; SURVIVAL RATE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; HUMANS; IMMUNOSUPPRESSION; LIVER NEOPLASMS; LIVER TRANSPLANTATION; PATIENT SELECTION; PILOT PROJECTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77953211203     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2010.01097.x     Document Type: Conference Paper

References (60)

1. European Liver Transplant Registry. Data Analysis Booklet. Paris: 2007: http://www.eltr.org.
2. Hoti E, Adam R. Liver transplantation for primary and metastatic liver cancers. Transpl Int 2008 12 : 1107.
3. Rea DJ, Rosen CB, Nagorney DM, Heimbach JK, Gores GJ. Transplantation for cholangiocarcinoma: when and for whom? Surg Oncol Clin N Am 2009 2 : 325.
4. Onaca N, Davis GL, Goldstein RM, Jennings LW, Klintmalm GB. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl 2007 3 : 391.
5. Mazzaferro V, Llovet JM, Miceli R, et al. Metroticket Investigator Study Group. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009 1 : 35.
6. Zimmerman MA, Trotter JF, Wachs M, et al. Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma. Liver Transpl 2008 5 : 633.
7. Toso C, Meeberg GA, Bigam DL, et al. De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects. Transplantation 2007 83 : 1162.
8. Rea DJ, Heimbach JK, Rosen CB, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005 3 : 451.
9. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 2006 7 : 982.
10. Tournigand C, Andre T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced CRC: a randomized GERCOR study. J Clin Oncol 2004 2 : 229.
11. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic CRC. N Engl J Med 2004 23 : 2335.
12. Van Cutsem E, Köhne CH, Hitre E, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 2009 14 : 1408.
13. Amado RG, Wolf M, Peeters M, et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol 2008 10 : 1626.
14. McCarter MD, Fong Y. Metastatic liver tumors. Semin Surg Oncol 2000 2 : 177.
15. Mentha G, Majno P, Terraz S, et al. Treatment strategies for the management of advanced colorectal liver metastases detected synchronously with the primary tumour. Eur J Surg Oncol 2007 33 (Suppl 2 S76.
16. Van den Eynde M, Hendlisz A. Treatment of colorectal liver metastases: a review. Rev Recent Clin Trials 2009 1 : 56.
17. National Institutes of Health Consensus Development Conference Statement: liver transplantation - June 20-23, 1983. Hepatology 1984 4 (1 Suppl 107S.
18. Aune S, Schistad G, Skulberg A. Human liver transplantation without azathioprine. Surg Gynecol Obstet 1972 5 : 727.
19. Pichlmayr R, Neuhaus P. Liver transplantation. Chirurg 1985 4 : 211.
20. Pichlmayr R. Is there a place for liver grafting for malignancy? Transplant Proc 1988 1 (Suppl 1 478.
21. Mühlbacher F, Piza F. Orthotopic liver transplantation for secondary malignancies of the liver. Transplant Proc 1987 19 : 2396.
22. Mühlbacher F, Huk I, Steininger R, et al. Is orthotopic liver transplantation a feasible treatment for secondary cancer of the liver? Transplant Proc 1991 23 : 1567.
23. Kappel S, Kandioler D, Steininger R, et al. Genetic detection of lymph node micrometastases: a selection criterion for liver transplantation in patients with liver metastases after colorectal cancer. Transplantation 2006 1 : 64.
24. Nordic Liver Transplant Registy. http://www.sts.org
25. Belle SH, Beringer KC, Detre KM. An update on liver transplantation in the United States: recipient characteristics and outcome. Clin Transpl 1995 19.
26. Robinson P. Hepatocellular carcinoma: development and early detection. Cancer Imaging 2008 8 (Suppl A S128.
27. Kattan MW, Gönen M, Jarnagin WR, et al. A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer. Ann Surg 2008 247 : 282.
28. Pawlik TM, Choti MA. Shifting from clinical to biologic indicators of prognosis after resection of hepatic colorectal metastases. Curr Oncol Rep 2007 3 : 193.
29. Nagorsen D, Voigt S, Berg E, Stein H, Thiel E, Loddenkemper C. Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival. J Transl Med 2007 5 : 62.
30. Sandel MH, Dadabayev AR, Menon AG, et al. Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: role of maturation status and intratumoral localization. Clin Cancer Res 2005 7 : 2576.
31. Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006 313 : 1960.
32. Abdel-Misih SR, Schmidt CR, Bloomston PM. Update and review of the multidisciplinary management of stage IV colorectal cancer with liver metastases. World J Surg Oncol 2009 7 : 72.
33. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004 239 : 818.
34. Nordlinger B, Van Cutsem E, Gruenberger T, et al. European Colorectal Metastases Treatment Group; Sixth International Colorectal Liver Metastases Workshop. Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol 2009 6 : 985.
35. Neeff H, Hörth W, Makowiec F, et al. Outcome after resection of hepatic and pulmonary metastases of colorectal cancer. J Gastrointest Surg 2009 13 : 1813.
36. Carpizo DR, D'Angelica M. Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease. Ann Surg Oncol 2009 16 : 2411.
37. Rama N, Monteiro A, Bernardo JE, Eugénio L, Antunes MJ. Lung metastases from colorectal cancer: surgical resection and prognostic factors. Eur J Cardiothorac Surg 2009 35 : 444.
38. Yamakado K, Inoue Y, Takao M, et al. Long-term results of radiofrequency ablation in colorectal lung metastases: single center experience. Oncol Rep 2009 22 : 885.
39. de Jong MC, Mayo SC, Pulitano C, et al. Repeat Curative Intent Liver Surgery is Safe and Effective for Recurrent Colorectal Liver Metastasis: Results from an International Multi-institutional Analysis. J Gastrointest Surg 2009 13 : 2141.
40. Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004 240 : 644.
41. Adam R, Wicherts D, de Haas RJ, et al. Patients with initially unresectable colorectal Liver Metastases: Is There a Possibility of Cure? J Clin Oncol 2009 27 : 1829.
42. de Jong MC, Pulitano C, Ribero D, et al. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg 2009 250 : 440.
43. Fung J, Kelly D, Kadry Z, Patel-Tom K, Eghtesad B. Immunosuppression in liver transplantation: beyond calcineurin inhibitors. Liver Transpl 2005 11 : 267.
44. Chan S, Scheulen ME, Johnston S, et al. Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer. J Clin Oncol 2005 23 : 5314.
45. Atkins MB, Hidalgo M, Stadler WM, et al. Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma. J Clin Oncol 2004 22 : 909.
46. Yadav RV, Indudhara R, Kumar P, Chugh KS, Gupta KL. Cyclophosphamide in renal transplantation. Transplantation 1988 45 : 421.
47. Gallimore AM, Simon AK. Positive and negative influences of regulatory T cells on tumour immunity. Oncogene 2008 27 : 5886.
48. Kingsley CI, Karim M, Bushell AR, Wood KJ. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002 168 : 1080.
49. Dueland S, Andersen M, Foss A. Quality of life (QoL) in colorectal cancer liver transplant patients. J Clin Oncol 2009 (27), ASCO-GI abstract nr. 438.
50. van der Hilst CS, Ijtsma AJ, Slooff MJ, Tenvergert EM. Cost of liver transplantation: a systematic review and meta-analysis comparing the United States with other OECD countries. Med Care Res Rev 2009 66 : 3.
51. Aaserud M, Kristiansen I S, Neilson A, et al. Helseøkonomisk evaluering av bevacizumab ved metastatisk kolorektalcancer. Rapport fra Kunnskapssenteret nr 23 - 2007. ISBN 978-82-8121-186-5 ISSN 1890-1298. (Summary in english at: http://www.kunnskapssenteret.no)
52. Movik E, Hamidi V, Aaserud M, Neilson AR, Klemp M. Helseøkonomisk evaluering av cetuximab ved metastatisk kolorektalcancer. Rapport Nr 10-2008 Nasjonalt kunnskapssenter. (Summary in english at: http://www.kunnskapssenteret. no).
53. Margarit C, Charco R, Hidalgo E, Allende H, Castells L, Bilbao I. Liver transplantation for malignant diseases: selection and pattern of recurrence. World J Surg 2002 26 : 257.
54. At http://www.sts.org
55. At http://www.eltr.org.
56. At http://www.unos.org.
57. Watt KD, Lyden ER, McCashland TM. Poor survival after liver retransplantation: is hepatitis C to blame? Liver Transpl 2003 9 : 1019.
58. McCashland T, Watt K, Lyden E, et al. Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study. Liver Transpl 2007 13 : 1246.
59. Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Eng Med 2007 356 : 1545.
60. Yamada T, Tanaka K, Uryuhara K, Ito K, Takada Y, Uemoto S. Selective hemi-portocaval shunt based on portal vein pressure for small-for-size graft in adult living donor liver transplantation. Am J Transplant 2008 8 : 847.